Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-08-02 02:02 UTC

BIOMED PULSE

August 2, 2026 | Your daily briefing on longevity, viruses, and new cures

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in the Democratic Republic of Congo has now reached 2,124 confirmed cases and 828 deaths as of July 15, with the DRC outbreak intensifying and spreading geographically beyond its origin in Ituri Province. Mood: tense on the outbreak front, cautiously watchful on longevity science.

🦠 OUTBREAKS & VIRUSES

BUNDIBUGYO VIRUS DISEASE (EBOLA) — DRC AND UGANDA: INTENSIFYING

  • As of July 15, 2026, a cumulative 2,124 confirmed cases including 828 deaths have been reported from the DRC, with cross-border transmission to Uganda ongoing. [1]
  • The August 1 WHO DON update confirms sustained transmission and continued geographic spread beyond Mongbwalu Health Zone, Ituri Province, where the outbreak was initially confined. [2]
  • The case fatality ratio among confirmed cases remains alarmingly high; the outbreak was first detected May 14, 2026, when DRC's Institut national de recherche biomédicale confirmed Bundibugyo virus, a filovirus last seen in a 2007-2008 outbreak in Uganda. [3]
  • CDC has activated enhanced Ebola airport screening at Washington-Dulles International and Atlanta airports to intercept returning travelers. [4] [5]

CYCLOSPORA OUTBREAK — TACO BELL LETTUCE, FIVE STATES

  • Shredded iceberg lettuce served at Taco Bell locations is the confirmed source of a Cyclospora cayetanensis outbreak affecting 1,644 sick people across five states as of July 17, 2026. [6]
  • The outbreak has since expanded to four additional states as of July 24, 2026; CDC is advising consumers to avoid the implicated product. [7]
  • Cyclospora is a single-celled intestinal parasite spread through contaminated food or water; illness causes prolonged watery diarrhea and can last weeks without treatment. [6] [7]

WEST NILE VIRUS — EARLY SEASON, RECORD CASES

  • CDC reported an early and elevated West Nile virus season ahead of the July 4 holiday weekend, with record case counts driving a public advisory to use EPA-registered repellents and wear long sleeves outdoors. [8]
  • West Nile virus is transmitted by Culex mosquitoes; most infected people have no symptoms, but roughly 1 in 150 develops severe neurological disease. [8]

E. COLI OUTBREAK — FROZEN BLUEBERRIES

  • CDC issued a food safety alert on July 7, 2026, warning of a recall of frozen blueberries linked to an E. coli outbreak; consumers are advised not to eat recalled product. [9]

ANDES HANTAVIRUS — M/V HONDIUS CRUISE SHIP

  • The fifth WHO Disease Outbreak News update (July 2, 2026) confirmed additional cases of Andes hantavirus (ANDV) linked to the M/V Hondius cruise ship, first reported to WHO on May 2, 2026. [10]
  • Andes hantavirus causes hantavirus pulmonary syndrome, a severe respiratory illness with high fatality; it is unique among hantaviruses in being the only species with documented human-to-human transmission. [10]
  • A June 24 CDC telebriefing transcript confirmed ongoing U.S. government monitoring of affected American passengers.

MPOX — RECOMBINANT CLADE Ib/IIb STRAIN

  • WHO reported in February 2026 two documented cases of a recombinant MPXV strain comprising both clade Ib and clade IIb genomic elements, a naturally occurring but epidemiologically significant development.
  • Recombination can theoretically alter transmissibility or immune escape properties; WHO is conducting ongoing genomic surveillance.

MEASLES — BANGLADESH NATIONWIDE SURGE

  • Bangladesh reported 19,161 suspected measles cases and 2,897 laboratory-confirmed cases spanning 58 of 64 districts across all eight divisions as of April 23, 2026.
  • The WHO DON noted the outbreak triggered a national IHR notification; measles globally infected 10.3 million people in 2023 according to a prior CDC report.

NIPAH VIRUS — KERALA, INDIA

  • On June 11, 2026, Kerala's State Health Department confirmed one laboratory-confirmed case of Nipah virus (NiV) infection in Kozhikode District, an adult male with neurological presentation hospitalized June 10.
  • Nipah virus carries a case fatality rate of 40-75% and has no approved treatment; Kerala has experienced repeated NiV outbreaks since 2018 due to its bat reservoir population.

AVIAN INFLUENZA A(H9N2) — ITALY

  • Italy notified WHO on March 21, 2026, of a human A(H9N2) case in an adult male returning from Senegal, confirmed by next-generation sequencing; no human-to-human transmission was identified.

NEW CDC DIRECTOR SWORN IN

  • Susan Monarez, Ph.D., was sworn in as CDC Director on July 31, 2025, under HHS Secretary Robert F. Kennedy Jr., advancing the Make America Healthy Again agenda.

🧬 LONGEVITY & AGING

EMERIN AND TAU: A NEW NUCLEAR AGING LINK IN NEURONS

  • A study published in the journal Nucleus found that the mechanically-sensitive nuclear envelope protein emerin is elevated in neurons exposed to tau, the protein that aggregates in Alzheimer's disease and other tauopathies.
  • The finding links nuclear mechanotransduction — how cells sense and respond to physical forces at the nucleus — to tau-induced cytoskeletal remodeling, pointing to a potential pathway by which tauopathy drives neurodegeneration.
  • Authors Sohn, Pardo, Frost, and colleagues at UT Health San Antonio used this mechanism to connect nuclear structural changes to the aging brain's vulnerability.

METFORMIN FOR PHYSICAL FUNCTION IN OLDER ADULTS WITH OBESITY — DEMFOS TRIAL

  • The DEMFOS randomized controlled trial published in Lancet Healthy Longevity tested metformin added to lifestyle intervention versus lifestyle intervention alone in older adults with obesity, assessing physical function as the primary endpoint.
  • An accompanying editorial by Witham and McDonald in the same issue cautioned against inflated expectations for metformin as a broad anti-frailty agent, calling for careful interpretation of the data.
  • Metformin, a diabetes drug with a long track record of safety, has been intensively studied for longevity effects due to its activation of AMPK and reduction of cellular senescence markers.

SENESCENCE MARKER P16INK4A — ANTIBODY VALIDATION MATTERS

  • Pipella and Thompson published in Islets highlighting that antibody choice critically affects detection of p16INK4A, the canonical cyclin-dependent kinase inhibitor and cellular senescence marker, in pancreas tissue by immunohistochemistry.
  • This methodological finding has broad relevance for longevity research: unreliable p16INK4A measurement can distort conclusions about beta-cell senescence and diabetes-aging links.

COLLAGEN XVII AND EPIDERMAL STEM CELL PHOTOAGING

  • Wang and colleagues published in Annals of Medicine showing recombinant human collagen XVII protects epidermal stem cells from blue-light-induced photoaging by downregulating the Notch signaling pathway.
  • Epidermal stem cell exhaustion is a hallmark of skin aging; collagen XVII loss has previously been linked to stem cell attrition and accelerated skin aging.

TELOMERE REPAIR IN CANCER CELLS — PML BODIES AND LAMIN B1

  • Salmina and colleagues published in Nucleus examining how telomeric DNA repair and misrepair interact dynamically with PML nuclear bodies and lamin B1 in doxorubicin-treated cancer cells.
  • The research adds to understanding of how nuclear architecture governs genome stability at chromosome ends, a process central to both cancer and normal cellular aging.

LYSOSOMAL AMPK ACTIVATION FOR FATTY LIVER DISEASE

  • Zhu and colleagues published in Bioactive Materials reporting that targeting ROAM1 with UDP-GlcNAc nanosheets selectively activates lysosomal AMPK to resolve metabolic dysfunction-associated steatotic liver disease (MASLD) in preclinical models.
  • AMPK activation via the lysosomal pathway — distinct from metformin's mechanism — represents a potentially more targeted route to address liver aging and metabolic disease simultaneously.

GESTALT BIOMARKER STUDY — ACTIVE ENROLLMENT

  • The NIH-sponsored GESTALT (Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing) study, NCT02339012, continues to enroll participants to identify blood and tissue biomarkers that predict quality of life and disease risk in old age.

💊 NEW CURES & APPROVALS

VEKLURY (REMDESIVIR) — GILEAD SCIENCES, SUPPLEMENTAL APPROVAL

  • Gilead Sciences received a supplemental approval (SUPPL AP) for Veklury (remdesivir) under NDA214787; remdesivir is an antiviral nucleotide prodrug originally developed for Ebola and repurposed as an intravenous treatment for SARS-CoV-2 requiring hospitalization.

QLONILIK (CLONIDINE HYDROCHLORIDE) — CMP DEV LLC, ORIGINAL APPROVAL

  • CMP Dev LLC received an original new drug approval (ORIG AP) for Qlonilik (clonidine hydrochloride) under NDA221094; clonidine is an alpha-2 adrenergic agonist used for hypertension and attention-related conditions.

MYCOPHENOLATE FORMULATIONS — MULTIPLE SUPPLEMENTAL APPROVALS

  • Multiple manufacturers including Roche Palo (CellCept, NDA050759), Hikma (ANDA065410), Azurity (Myhibbin, NDA216482), Apotex, Accord Healthcare, Alkem Labs, Yichang Humanwell, Rising, and Concord Biotech received supplemental approvals for mycophenolate mofetil or mycophenolate sodium formulations, used as immunosuppressants in organ transplant recipients.

METFORMIN HYDROCHLORIDE — SUN PHARMACEUTICAL INDUSTRIES, SUPPLEMENTAL APPROVAL

  • Sun Pharmaceutical Industries received a supplemental approval for metformin hydrochloride (ANDA077124), the widely used biguanide antidiabetic drug that is also under active investigation for longevity and frailty.

🧪 CLINICAL TRIALS

GESTALT — AGING BIOMARKER LONGITUDINAL STUDY (NCT02339012)

  • This NIA-sponsored study at NIH continues enrolling older volunteers to map genetic and epigenetic biomarkers of aging longitudinally, with the aim of identifying predictors of healthy versus pathological aging.

DEMFOS — METFORMIN PLUS LIFESTYLE IN OLDER ADULTS WITH OBESITY

  • The DEMFOS trial (randomized, controlled) tested metformin added to lifestyle intervention for physical function in older adults with obesity; results published in Lancet Healthy Longevity represent one of the most rigorous geriatric metformin trials to date.

OCU500 INTRANASAL COVID-19 VACCINE — PHASE 1 (NCT07536308)

  • A Phase 1 dose-escalation trial is evaluating OCU500, a ChAd36 vector encoding SARS-CoV-2 spike protein delivered intranasally and by inhalation, in healthy adults aged 18-64 who previously completed primary COVID-19 vaccination plus at least one booster.
  • The mucosal route of administration targets upper airway immunity and could provide sterilizing protection not achieved by intramuscular vaccines.

CORNELIAN CHERRY SUPPLEMENTATION IN METABOLIC SYNDROME (NCT07739602)

  • A randomized, double-blind, placebo-controlled parallel-group study evaluated six-month oral supplementation with 8 g daily of Cornus mas (Cornelian cherry) fruit lyophilizate in patients with metabolic syndrome, with outcomes addressing cardiovascular and metabolic risk factors.

YOUTH-ONSET TYPE 2 DIABETES AND HEART DISEASE — YOUNG AT HEART COHORT (NCT06730113)

  • This prospective cohort study is tracking vascular disease outcomes in children and young adults with type 2 diabetes, a population where rates have tripled over 40 years and vascular complications appear faster than in adult-onset disease.

BARICITINIB FOR JOB SYNDROME (NCT07262983)

  • A safety and tolerability trial of baricitinib, a JAK1/JAK2 inhibitor, is enrolling patients with autosomal dominant hyper-IgE syndrome (Job syndrome) who have lupus-like disease or atopic dermatitis; JAK inhibition is also under investigation for senescence-related inflammation.

📢 PUBLIC HEALTH

SALMONELLA OUTBREAK — BACKYARD POULTRY, NATIONWIDE

  • An ongoing multistate Salmonella outbreak linked to backyard poultry has sickened people across 13 states, with over a quarter of cases in children under 5 years old, as of the most recent CDC update.
  • CDC advises handwashing immediately after handling poultry or their environment and keeping live poultry out of the home, especially away from young children.

SALMONELLA OUTBREAK — FROZEN SPROUTED BEANS

  • As of July 17, 2026, 11 people from 10 states have been sickened with the same Salmonella strain linked to frozen sprouted beans; CDC has posted a food safety alert.

LISTERIA OUTBREAK — REQUESÓN/SOFT RICOTTA CHEESE

  • CDC issued a Listeria monocytogenes outbreak warning on June 5, 2026, linked to requesón and soft ricotta cheese; Listeria is especially dangerous for pregnant women, newborns, older adults, and immunocompromised individuals.

NEW CDC YOUTH CAMPAIGN — FREE MIND

  • CDC launched the Free Mind campaign on August 5, 2025, providing teens with evidence-based resources about substance use and mental health, part of a broader push to address adolescent behavioral health.

NEW WORLD SCREWWORM — CDC EMERGENCY OPERATIONS CENTER ACTIVATED

  • CDC activated its Emergency Operations Center on June 12, 2026, to respond to New World Screwworm (Cochliomyia hominivorax), a parasitic fly whose larvae infest living tissue; the activation signals concern about potential spread to humans or animals in the U.S.

INFANT BOTULISM — NARA ORGANICS FORMULA RECALL

  • CDC issued an outbreak update on June 13, 2026, urging parents to immediately stop using all Nara Organics Whole Milk Organic Infant Formula linked to confirmed infant botulism cases.

DRUG-RESISTANT BACTERIA — SHARP RISE DOCUMENTED

  • A CDC report released September 23, 2025, found a dramatic increase in dangerous drug-resistant bacteria, continuing a long-term trend that threatens to erode the effectiveness of existing antibiotic treatments.

CONGENITAL SYPHILIS — 12TH CONSECUTIVE YEAR OF INCREASE

  • CDC data published September 24, 2025, showed U.S. newborn syphilis cases increased for the 12th consecutive year in 2024, underscoring continued gaps in prenatal screening and treatment.

This briefing is informational only and does not constitute medical advice. Always consult a qualified healthcare provider for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  3. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  4. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  5. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  6. Shredded iceberg lettuce served at Taco Bell locations is sour… — CDC Newsroom
  7. Cyclospora outbreak linked to iceberg lettuce expanded to four… — CDC Newsroom
  8. CDC Encourages Americans to Stay Mosquito Bite-Free during Ame… — CDC Newsroom
  9. CDC warns of <em>E. coli</em> outbreak linked to frozen bluebe… — CDC Newsroom
  10. Hantavirus outbreak linked to cruise ship travel, Multi-locations — WHO Disease Outbreak News

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260802-02-v46 · 2026-08-02 02:02 UTC · pulse.uzylab.com

Read next